Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$117.51K

Rothblatt Martine A Chairperson & CEO

Transaction date Sep 22, 2026
Public filing date Sep 23, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$497.59 Sep 22, 2026
First close after public filing
$472.21 Sep 24, 2026
30-day return after filing
+24.41% Through Oct 23, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
240 shares @ $489.61
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000147
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$5.82M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Sep 22, 2026 $737.7K
United Therapeutics Corp UTHR Sale Sep 22, 2026 $79.85K
United Therapeutics Corp UTHR Exercise Sep 22, 2026 $1.12M
United Therapeutics Corp UTHR Current Sale Sep 22, 2026 $117.51K
United Therapeutics Corp UTHR Sale Sep 22, 2026 $207.99K
United Therapeutics Corp UTHR Sale Sep 22, 2026 $361.7K
United Therapeutics Corp UTHR Sale Sep 22, 2026 $309.4K
United Therapeutics Corp UTHR Sale Sep 22, 2026 $812.14K
United Therapeutics Corp UTHR Sale Sep 22, 2026 $661.36K
United Therapeutics Corp UTHR Sale Sep 22, 2026 $737.29K
United Therapeutics Corp UTHR Exercise Sep 22, 2026 $0
United Therapeutics Corp UTHR Sale Sep 22, 2026 $675.91K